bxl017

Bo Lu, MD

Contact Dr. Lu

G-301 Bodine Cancer Center
111 S. 11th Street
Philadelphia, PA 19107

(215) 955-6705
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. IGFBP3 modulates lung tumorigenesis and cell growth through IGF1 signaling
  2. Comparison of Online 6 Degree-of-Freedom Image Registration of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac X-Ray for Intracranial Radiosurgery
  3. Neutrophil to lymphocyte ratio associated with prognosis of lung cancer
  4. Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non–Small-Cell Lung Cancer (RTOG 3505)
  5. siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
  6. Brigatinib and the new generation of ALK-inhibitors for non-small cell lung cancer
  7. Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer
  8. Immune biomarkers of treatment failure for a patient on a phase i clinical trial of pembrolizumab plus radiotherapy
  9. Nitrilase 1 modulates lung tumor progression in vitro and in vivo
  10. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  11. Systemic therapy for echinoderm microtubule-associated proteinlike 4 anaplastic lymphoma kinase non-small cell lung cancer brain metastases
  12. Lung cancer screening: Not all nodules are created equal
  13. Biodistribution and Pharmacokinetics Study of siRNA-loaded Anti-NTSR1-mAb-functionalized Novel Hybrid Nanoparticles in a Metastatic Orthotopic Murine Lung Cancer Model
  14. Coadministration of trametinib and palbociclib radiosensitizes KRAS-mutant non-small cell lung cancers in vitro and in vivo
  15. BH3 mimetic ABT-737 sensitizes colorectal cancer cells to ixazomib through MCL-1 downregulation and autophagy inhibition
  16. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
  17. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer
  18. Nab-paclitaxel in combination with weekly carboplatin with concurrent radiotherapy in stage III non-small cell lung cancer
  19. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests
  20. Serum clusterin as a tumor marker and prognostic factor for patients with esophageal cancer